September 5, 2024
TOPLINE: Older adults with acute uncomplicated appendicitis who were operated on within 1 day of admission were less likely to die in the hospital compared with […]
September 5, 2024
TOPLINE: A history of migraine is not associated with an elevated risk for Parkinson’s disease (PD) in women, regardless of headache frequency or migraine subtype, a […]
September 5, 2024
TOPLINE: Women who received false-negative mammography results were less likely to return for future screenings. METHODOLOGY: Researchers analyzed more than three million screening mammograms from more […]
September 5, 2024
TOPLINE: In patients with prostate cancer, androgen receptor pathway inhibitors (ARPIs) extended the median time to no longer clinically benefitting (NLCB) to 11.1 months vs the […]
September 5, 2024
TOPLINE: Childhood obesity is linked to a higher risk for pediatric skin diseases linked to immunity, including alopecia areata, atopic dermatitis, and psoriasis. Transitioning from normal […]
September 4, 2024
TOPLINE: Patients with both rheumatoid arthritis (RA) and atrial fibrillation (AF) have a higher risk for ischemic stroke than those with only AF. They are also […]
September 4, 2024
TOPLINE: Patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) treated with immune checkpoint inhibitors (ICIs) show comparable survival outcomes whether they continued […]
September 4, 2024
TOPLINE: Nearly 80% of patients with metastatic uveal melanoma experienced skin toxicities with tebentafusp, a targeted immunotherapy, according to a study that also suggests that the […]
September 4, 2024
TOPLINE: Prehospital pulse-dose glucocorticoid treatment in patients with ST-segment elevation myocardial infarction (STEMI) does not reduce the final infarct size at 3 months but may improve […]